GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for 6,7-dimethyl-8-ribityllumazine synthase (A5FNH3)

Analyse AlphaFold monomer V2.0 prediction for 6,7-dimethyl-8-ribityllumazine synthase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A5FNH3
Type
protein
Length
190 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x9F605311B7e26e76340423EfAfbE5e2EFc7A0b7C
Molecule
6,7-dimethyl-8-ribityllumazine synthase
UniProt
A5FNH3
Pockets
1 · best druggability 0.28

Structure

1 distinct chain · 43% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A6,7-dimethyl-8-ribityllumazine synthaseprotein19043% helix, 18% strandA5FNH3

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1530.280.7415empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.